News – Page 1065 – Endpoints News

David Hung makes a quick, abrupt exit at Axovant after humiliating setbacks

8 years ago

What's he thinking about? Vivek Ramaswamy lines up a heavyweight title fight for a late-stage diabetes drug

8 years ago

Celgene prices $4.5B senior notes to help buy Juno; Health Affairs study says Novartis prices its CAR-T too high

8 years ago

Allergan snatches Australian aesthetics company Elastagen for $95M

8 years ago

CEO Eliot Forster leaves Immunocore as the UK biotech unicorn hunts cash

8 years ago

Bioverativ execs haul in new fortunes after patiently waiting for Sanofi to bid up its $11.6B exclusive buyout

8 years ago

Market crash slumps biotech as investors yank $1.2B from funds

8 years ago

CSO Bill Lundberg transitions to advisor role at CRISPR Therapeutics; Prothena loses CMO Sarah Noonberg; Sanofi vet ...

8 years ago

Sarepta halts its golodirsen Duchenne MD study in UK after patient experiences adverse event

8 years ago

A week of UK deals exemplifies China’s growing role in global biotech investment

8 years ago

Seattle Genetics seeds a new immuno-oncology collaboration with the protein explorers at Pieris

8 years ago

Scientists toss another Alzheimer’s program into the scrap heap as PhII fails

8 years ago

Sage seeks $575M in public offering; Pfizer inks discovery pact with Chinese firm

8 years ago

GV-backed startup Rani gets $53M from new investors for 'robotic pill'

8 years ago

In latest blow to Teva, CGRP migraine med could be delayed while rivals race towards the finish line

8 years ago

Madrigal touts a mid-stage success in HeFH, cutting bad cholesterol in a competitive field

8 years ago

Genomics meets blockchain: Harvard team featuring George Church launches peer-to-peer genome sequencing startup

8 years ago

No more Mr Nice Guy: GlaxoSmithKline is coming out of its corner swinging

8 years ago

Gilead gets a blockbuster boost from an FDA OK of HIV triplet Biktarvy — and rival GSK fires back

8 years ago

Case Western/Sangamo get $11M grant to wipe out HIV; Sage's depression drug, GSK's vaccine get breakthrough therapy ...

8 years ago

Verastem takes AbbVie’s blood cancer castoff to the FDA

8 years ago

Sanofi sounds taps on a half dozen drug programs in latest pipeline cleanup

8 years ago

Biogen scuttles a Tysabri program after the drug fails stroke test, thinning the pipeline

8 years ago

North of a billion biotech VC dollars to come from C-Bridge, Rothschild as global biopharma capital flows

8 years ago

First page Previous page 1062 1063 106410651066 1067 1068 Next page Last page